Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
11/2005
11/24/2005WO2005111042A1 Novel indole derivatives as selective androgen receptor modulators (sarms)
11/24/2005WO2005111029A1 Novel substituted thiophenecarboxamides, their production and their use as medicaments
11/24/2005WO2005111028A1 Novel indole derivatives as selective androgen receptor modulators (sarms)
11/24/2005WO2005111025A1 3-piperidinylisochroman-5-ols as dopamine agonists
11/24/2005WO2005111018A1 Pyridazinone derivatives, methods for producing them and their use as pharmaceuticals
11/24/2005WO2005111014A1 Substituted thiophen-carboxylic acid amides, the production and the use thereof in the form of a drug
11/24/2005WO2005111013A1 Substituted thiophene-2-carboxylic acid amides, the production thereof and the use thereof as drugs
11/24/2005WO2005111003A1 Amino-tetrazoles analogues and methods of use
11/24/2005WO2005111001A1 Novel fused heterocycles and uses thereof
11/24/2005WO2005110988A1 Pyridone compounds as inhibitors of bacterial type iii protein secretion systems
11/24/2005WO2005110987A1 Piperidine derivatives as nk1 and nk3 antagonists
11/24/2005WO2005110971A1 Heteroaryl substituted cyclohexyl-1,4-diamine derivatives
11/24/2005WO2005082856A3 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
11/24/2005WO2005046604A3 Heteroaryl-hydrazone compounds
11/24/2005WO2004113297A9 Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
11/24/2005US20050261502 2-Amino-4-(1,3-benzodioxol-5-yl)-6-benzyloxy-3,5-pyridinedicarbonitrile, acting as adenosine-receptor-selective ligands, for the prophylaxis and/or treatment of cardiovascular disorders
11/24/2005US20050261501 e.g. 1-({[9-(hydroxymethyl)-3-oxaspiro[5.5]undec-9-yl]amino}acetyl)-2-pyrrolidinecarbonitrile; dipeptidyl-peptidase IV inhibitor; antidiabetic, hypoglycemic agent; non-insulin dependent diabetes, obesity
11/24/2005US20050261496 3-(Morpholin-4-ylsulfonyl)-5-(1,3-thiazol-2-yl)-1H-indole-2-carboxamide; inhibiting, modulating and/or regulating signal transduction of both receptor and non-receptor tyrosine kinases; anticarcinogenic, -diabetic, -arhtritic, -inflammatory agents; psoriasis; angiogenesisinhibitors; liver cirrhosis
11/24/2005US20050261353 Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
11/24/2005US20050261346 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide;modified amidine elements of high potency in vitro, excellent pharmacological and pharmaceutical properties in vivo
11/24/2005US20050261339 Jun N-terminal kinase inhibitors; neurodegenerative diseases; Alzheimer's disease; amyotrophic lateral sclerosis; multiple sclerosis; spinocerebellar ataxia
11/24/2005US20050261313 For angiogenesis mediated diseases; cancer; acylation, cyclization and Heck-type reduction
11/24/2005US20050261309 Imidazole compounds
11/24/2005US20050261305 Cyclic protein tyrosine kinase inhibitors
11/24/2005US20050261301 e,g, 1,5-bis(5-acetyl-4,7-dimethoxybenzofuran-6-yloxy)pentane;potassium channel modulator; antiinflammatory agent, autoimmune diseases; immunosuppressant; multiple sclerosis, rejection of foreign organ transplants
11/24/2005US20050261294 Substituted heteroaryl derivatives, compositions, and methods of use
11/24/2005US20050261293 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/24/2005US20050261287 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
11/24/2005US20050261281 Pharmaceutical compounds
11/24/2005US20050261279 antipsychotic agents; phenylsulfonyl compounds; 7-Methoxy-8-(3-phenoxy-benzenesulfonyl)-2,3,4,5-tetrahydro-1H-3-benzazepine; schizophrenia
11/24/2005US20050261277 Pentacyclic oxepines and derivatives thereof, compositions and methods
11/24/2005US20050261271 Dipeptidyl peptidase inhibitors
11/24/2005US20050261269 New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
11/24/2005US20050261244 Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
11/24/2005US20050261203 Azabicyclo-octane inhibitors of IAP
11/24/2005DE102004021779A1 Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel New beta-agonists, to processes for their preparation and their use as medicaments
11/24/2005CA2566212A1 Heteroaryl-substituted cyclohexyl-1,4-diamine derivatives
11/24/2005CA2565953A1 Piperidine derivatives as nk1 and nk3 antagonists
11/24/2005CA2565407A1 Compounds for enzyme inhibition
11/24/2005CA2565211A1 Amino-tetrazoles analogues and methods of use
11/24/2005CA2565186A1 Substituted thiophen-carboxylic acid amides, the production and the use thereof in the form of a drug
11/24/2005CA2564952A1 Novel indole derivatives as selective androgen receptor modulators (sarms)
11/24/2005CA2564207A1 Novel substituted thiophenecarboxamides, their production and their use as medicaments
11/24/2005CA2562714A1 Substituted thiophene-2-carboxylic acid amides, the production thereof and the use thereof as drugs
11/24/2005CA2507712A1 Pharmaceutical compounds
11/23/2005EP1598351A1 Substituted N-pyrimidinyl-N'-thienyl(amino)sulfonylureas as herbicides
11/23/2005EP1598350A1 Pyrrolidines and thiazolidines derivatives, their preparation and their use in the treatment of hyperglycaemia and of type II Diabetis
11/23/2005EP1597254A1 Indole-derivative modulators of steroid hormone nuclear receptors
11/23/2005EP1597252A1 Pyridine derivatives as fungicidal compounds
11/23/2005EP1597249A1 Anthelmintic agents and insecticidal compositions
11/23/2005EP1597248A2 Sulfonamide derivatives as ppar modulators
11/23/2005EP1597247A1 Substituted 3-(benzoylureido)-thiophene derivatives, method for the production and use thereof
11/23/2005EP1597246A2 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
11/23/2005EP1597235A1 Non-nucleoside reverse transcriptase inhibitors
11/23/2005EP1597231A1 Derivatives of azasugars as anticancer agents
11/23/2005EP1597228A2 Substituted n-arylheterocycles, method for production and use thereof as medicaments
11/23/2005EP1503754B1 Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
11/23/2005EP1377550B9 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
11/23/2005EP1280777B1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/23/2005EP0811007B1 Pyrazol-4-yl-benzoyl derivatives and their use as herbicides
11/23/2005CN1701068A Novel compounds and their use
11/23/2005CN1699362A Thienyl substituted hexa-aryl bis-imidazole and method for preparing same
11/23/2005CN1699350A Processes and intermediates for preparing anti-cancer compounds
11/23/2005CN1699347A Substituted pyrazolyl benzenesulfonamides for the treatment of inflamation
11/23/2005CN1228338C Imidazole derivatives or salts thereof and drugs contg. derivatives or salts
11/23/2005CN1228337C Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands
11/22/2005US6967216 Neuropeptide Y receptor modulators; treating eating disorders
11/22/2005US6967208 Anticoagulants; cardiovascular disorders
11/22/2005US6967205 Compounds with antibacterial and antiparasitic properties
11/22/2005CA2180445C Chemical switching of taxo-diterpenoids between low solubility active forms and high solubility inactive forms
11/17/2005WO2005108844A2 Threaded connection for oil field applications
11/17/2005WO2005108390A1 Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders
11/17/2005WO2005108374A1 Insecticidal diazole and triazole derivatives
11/17/2005WO2005108373A1 Novel beta agonists, method for producing the same and their use as drugs
11/17/2005WO2005108370A1 Benzene compounds
11/17/2005WO2005108367A1 Compounds for treatment of neurodegenerative diseases
11/17/2005WO2005108362A1 (4, 5, 6, 7-tetrahydro-1-h-indol-7-yl) acetic acid derivatives for treatment of alzheimer's disease
11/17/2005WO2005108355A2 Dihydrobenzothiophenes
11/17/2005WO2005091752A3 Acrylonitrile derivatives for inflammation and immune-related uses
11/17/2005WO2005085177A3 Biaryl amino acids and their use in dna binding oligomers
11/17/2005WO2005079319A3 C10 cyclopentyl ester substituted taxanes
11/17/2005WO2005061462A3 Diaryl pyrazole derivatives and their use as neurokinin-3 receptor modulators
11/17/2005WO2005058834A3 Quinolines useful in treating cardiovascular disease
11/17/2005US20050256315 1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators
11/17/2005US20050256309 Tri-and bi-cyclic heteroaryl histamine-3 receptor ligands
11/17/2005US20050256180 drugs such as 1 -[4-(aminosulfonyl)phenyl]-8-{[(trifluoromethyl)sulfonyl]amino}-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide, used as antiinflammatory agents, antiarthritic agents, antipyretics or analgesics
11/17/2005US20050256174 Raf kinase inhibitors
11/17/2005US20050256170 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); e.g. (4-[(5-Phenyl-furan-2-carbonyl)-amino]-phenyl)-acetic acid or 5-Phenyl-furan-2-carboxylic acid [3-(1H-tetrazol-5-yl)-phenyl]-amide; dysmenorrhoea, preterm labour, glaucoma, immune disorders, inflammatory disorders
11/17/2005US20050256167 Preparation and use of imidazole derivatives for treatment of obesity
11/17/2005US20050256164 NK1 and NK3 antagonists
11/17/2005US20050256160 Beta-alanine derivatives and the use thereof
11/17/2005US20050256159 1,4-disubstituted piperidine derivatives and their use as 11,betahsd1 inhibitors
11/17/2005US20050256137 Pyridone compounds as inhibitors of bacterial type III protien secreation systems
11/17/2005US20050256130 Substituted piperazines
11/17/2005US20050256124 Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
11/17/2005US20050256121 Substituted 2,5-heterocyclic derivatives
11/17/2005US20050256120 Heterocyclo-substituted imidazoles for the treatment of inflammation
11/17/2005US20050256118 Bicyclic-substituted amines having cyclic-substituted monocyclic substituents
11/17/2005US20050256117 Ophthalmic compositions for treating ocular hypertension
11/17/2005US20050256107 New substituted thiophene carboxamides, process for their preparation and their use as medicaments
1 ... 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 ... 523